A New Era in Gene Therapy

11:00 AM - 12:00 PM (PDT), Wednesday, June 15, 2022

There has been tremendous progress in advancing gene therapies and delivering these life-changing medicines to patients worldwide. However, with these advancements come new challenges, from manufacturing bottlenecks to safe therapeutic vectors. As we enter a new era of gene therapy innovation, how are the next generation of genetic medicines addressing these concerns? Hear from a diverse panel of experts as they discuss novel approaches in development that have the potential to solve some of the greatest problems facing the field, including building manufacturing infrastructure with capacity to provide broader access to these medicines, utilizing novel non-viral vectors and innovation in vector engineering, improving cost efficiency, broadening the application of gene therapy to other hard-to-treat rare diseases but also to broad indications that impact millions of people worldwide.

Senior Science Writer
Genetic Engineering & Biotechnology News
Chief Executive Officer
Xalud Therapeutics, Inc.
Senior Vice President and Division Head of Gene Therapy Research and Technical Operations
Astellas Gene Therapies
Kriya Therapeutics
President, Founder and CEO
Taysha Gene Therapies